The main goal of this clinical trial is to check if the treatment is safe and well-tolerated. Researchers will compare the MR-301 active drug group with the placebo group to evaluate the safety and tolerability of the drug. Other measurements鈥�
- Investigator
- Thiago Santos Carneiro
- Status
- Accepting Candidates
- Ages
- 18 Years - 65 Years
- Sexes
- All